AI Blood Test Could Be Key to Measure Pancreatic Cancer Therapy Success
Researchers developed an AI-driven blood test, ARTEMIS-DELFI, that detects pancreatic cancer treatment response faster and more accurately.
Read MorePosted by Chris Wolski | May 21, 2025 | Pancreatic |
Researchers developed an AI-driven blood test, ARTEMIS-DELFI, that detects pancreatic cancer treatment response faster and more accurately.
Read MorePosted by Chris Wolski | May 21, 2025 | Immunoassay Reagents & test Kits |
The Guardant Hereditary Cancer test is a blood-based genetic screening tool that identifies inherited cancer risk variants.
Read MorePosted by Chris Wolski | May 12, 2025 | Molecular Diagnostic Analyzers |
Thermo Fisher Scientific has launched the Applied Biosystems TrueMark PGx SNP + CNV Real-Time PCR Solution.
Read MorePosted by Chris Wolski | May 5, 2025 | Fertility Testing |
Innovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.
Read MorePosted by Chris Wolski | May 1, 2025 | Cardiovascular |
A major new study shows that measuring two specific lipoprotein markers provides a more accurate assessment of heart disease risk.
Read More